Skip to main content

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Agency: National Institutes of Health

Assistance Listings
  • 93.394 -- Cancer Detection and Diagnosis Research

Forecasted opportunityLast Updated: Jul 14, 2026

Important dates

  • Forecasted post date: January 15, 2027
  • Forecasted application due date: June 4, 2027
  • Forecasted award date: April 1, 2028
  • Forecasted project start date: April 15, 2028
  • Fiscal Year: 2028

Award details

  • Expected project funding: $6,600,000
  • Expected awards: 14

Award min.

Not specified

Award max.

$300,000

  • Funding opportunity number:RFA-CA-28-002
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: July 14, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies for cancer research or clinical care. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development, enhancements, optimizations, and rigorous technical validation to encourage adoption by the research community.

Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, and/or epidemiology. Projects that are in-scope include technologies with new or significantly improved technical capabilities to measure, analyze, model, or interrogate cancer-related systems. These may include, but are not limited to, advanced molecular and cellular analysis platforms, multi-omic and spatial profiling methods, imaging and sensing technologies, immuno-engineering approaches, and innovations in biospecimen processing, modeling, and quality assessment. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer applications. Projects proposing application of existing technologies where the novelty resides in the clinical target or biological question being pursued are not appropriate for this solicitation. 

This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. 

Eligibility

Business

  • Small businesses
  • For-profit organizations other than small businesses

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Education

  • Private institutions of higher education
  • Independent school districts
  • Public and state institutions of higher education

Government

  • Public and Indian housing authorities
  • State governments
  • Federally recognized Native American tribal governments
  • County governments
  • City or township governments
  • Special district governments

Miscellaneous

  • Other

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

Documents

No documents are currently available.

Agency contact information

Email: NCI-IMAT@nih.gov

NCI-IMAT@nih.gov

IMAT Program Contact 240-255-0917

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov